Abstract
Intragastric administration (100 - 200 μmol/kg) of tacrine (THA) or bis(7)-THA could cause an acute and dose-dependent increase in plasma alanine aminotransferases activity in mice at 6 h after the drug administration. The increase in plasma enzyme activity was associated with an increase in hepatic malondialdehyde level, an indirect index of oxidative tissue damage. Pretreating mice with schisandrin B (Sch B), an active dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis, at a daily dose of 0.125 - 0.5 mmol/kg for 3 days protected against the THA/bis(7)-THA induced hepatic oxidative damage in a dose-dependent manner. Sch B treatment (0.025 - 0.5 mmol/kg/day × 5) also enhanced the passive avoidance-response in mice as assessed by the step-through task experiment. The ensemble of results suggests that Sch B may be useful for reducing the potential hepatotoxicity of THA/bis(7)-THA in anti-Alzheimer’s therapy.
Abbreviations
ALT:alanine aminotransferases
MDA:malondialdehyde
Sch B:schisandrin B
THA:tetrahyroaminoacridine
VE:α-tocopherol
Key words
Tacrine - bis(7)-tacrine - hepatotoxicity -
Schisandra chinensis
- Schisandraceae - schisandrin B - cognitive enhancement
References
-
1
Kristofikova Z, Fales E, Majer E, Klaschka J.
(3H)Hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer’s disease and multi-infarct dementia.
Experimental Gerontology.
1995;
30
125-36
-
2
Lawrence A D, Sahakian B J.
The cognitive psychopharmacology of Alzheimer’s disease: Focus on cholinergic systems.
Neurochemical Research.
1998;
23
787-94
-
3
Rocca W A, Amaducci L A, Schoenberg B S.
Epidemiology of clinically diagnosed Alzheimer’s disease.
Annals of Neurology.
1986;
19
415-24
-
4
Marquis J K.
Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine.
Biochemical Pharmacology.
1990;
40
1071-6
-
5
Freeman S E, Dawson R M.
Tacrine: a pharmacological review.
Progress in Neurobiology.
1991;
36
257-77
-
6
Watkins P B, Zimmerman H J, Knapp M J, Gracon S I, Lewis K W.
Hepatotoxic effects of tacrine administration in patients with Alzheimer’s disease.
Journal of American Medical Association..
1994;
271
992-8
-
7
O’Brien J T, Eagger S, Levy R.
Effects of tetrahydroaminoacridine on liver function in patients with Alzheimer’s disease.
Age and Aging.
1991;
20
129-31
-
8
Pang Y P, Quiram P, Jelacic T, Hong F, Brimijoin S.
Highly potent, selective, and low cost bis-tetrahydroaminoacrine inhibitors of acetylcholinesterase.
Journal Biological Chemistry.
1996;
271
23 646-9
-
9
Hancke J L, Burgos R A, Ahumada F.
Schisandra chinensis (Turcz.) Baill.
Fitoterapia.
1999;
70
451-71
-
10
Pang Y P, Hong F, Quiram P, Jelacic T, Brimijoin S.
Synthesis of alkylene linked bis-THA and alkylene linked benzyl-THA as highly potent and selective inhibitors and molecular probes of acetylcholinesterase.
Journal of Chemical Society Perkin Transactions.
1997;
1
171-6
-
11
Ip S P, Poon M KT, Wu S S, Che C T, Ng K H, Kong Y C, Ko K M.
Effect of schisandrin B on hepatic glutathione antioxidant system in mice: Protection against carbon tetrachloride toxicity.
Planta Medica.
1995;
61
398-401
-
12
Young I S, Trimble E R.
Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection.
Annals of Clinical Biochemistry.
1991;
28
504-8
-
13
Summers W K, Koehler A L, Marsh G M, Tachiki K, Kling A.
Long-term hepatotoxicity of tacrine.
Lancet.
1989;
1
729
-
14
Monteith D K, Emmerling M R, Garvin J, Theiss J C.
Cytotoxicity study of tacrine, structurally and pharmacologically related compounds using rat hepatocytes.
Drug and Chemical Toxicology.
1996;
19
71-84
-
15
Madden S, Woolf T F, Pool W F, Park B K.
An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes.
Biochemical Pharmacology.
1993;
46
13-20
-
16
Woolf T F, Pool W F, Bjorge S M, Chang T, Goel O P, Purchase CF 2 nd, Schroeder M C, Kunze K L, Trager W F.
Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.
Drug Metabolism and Disposition.
1993;
21
874-82
-
17
Monteith D K, Theiss J C.
The role of metabolism in the cytotoxicity of tetrahydroaminoacridine in hepatocytes.
The Toxicologist.
1993;
13
139 (abstract)
-
18
Wang H, Carlier P R, Ho W L, Wu D C, Lee N TK, Li C PL. et al .
Effects of bis(7)-tacrine, a novel anti-Alzheimer’s agent, on rat brain ache.
NeuroReport.
1999;
10
789-93
-
19
Stachlewitz R F, Arteel G E, Raleigh J A, Connor H D, Mason R P, Thurman R G.
Development and characterization of a new model of tacrine-induced hepatotoxicity: role of the sympathetic nervous system and hypoxia-reoxygenation.
Journal of Pharmacology and Experimental Therapeutics.
1997;
282
1591-9
-
20
Schemmer P, Connor H D, Arteel G E, Raleigh J A, Bunzendahl H, Mason R P. et al .
Reperfusion injury in livers due to gentle in situ organ manipulation during harvest involves hypoxia and free radicals.
Journal of Pharmacology and Experimental Therapeutics.
1999;
290
235-40
-
21
Dogterom P, Nagelkerke J F, Mulder G J.
Hepatotoxicity of terahydroaminoacridine in isolated rat hepatocytes: Effect of glutathione and vitamin E.
Biochemical Pharmacology.
1988;
7
2311-3
-
22
Mak D HF, Ip S P, Li P C, Poon M KT, Ko K M.
Effects of schisandrin B and α-tocopherol on lipid peroxidation, in vitro and in vivo
.
Molecular and Cellular Biochemistry.
1997;
165
161-5
-
23 Chang H M, But P PH. Pharmacology and Applications of Chinese Materia Medica. Vol. 1 Singapore; World Scientific 1986: 199-209
Dr. Robert K.M. Ko
Department of Biochemistry
Hong Kong University of Science & Technology
Clear Water Bay, Hong Kong
China
Email: bcrko@ust.hk
Fax: +852-2358 1552